XML 35 R20.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Intangible Assets | 12 Months Ended
--- | ---
Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract] |
Intangible Assets | Intangible Assets Goodwill and other intangible assets related to the former Diabetes Care business have been reclassified as Noncurrent Assets of Discontinued Operations for prior year periods. For additional information, see Note 2. Intangible assets at September 30 consisted of:
| 2022 |  | 2021
(Millions of dollars) | Gross Carrying Amount |  | Accumulated Amortization |  | Net Carrying Amount |  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Carrying Amount
Amortized intangible assets |  |  |  |  |  |  |  |  |  |  |
Developed technology | $ | 15,087 |  |  | $ | (5,979) |  |  | $ | 9,108 |  |  | $ | 14,399 |  |  | $ | (4,983) |  |  | $ | 9,417 |
Customer relationships | 4,853 |  |  | (2,170) |  |  | 2,683 |  |  | 4,653 |  |  | (1,838) |  |  | 2,815 |
Product rights | 97 |  |  | (72) |  |  | 25 |  |  | 123 |  |  | (83) |  |  | 40 |
Trademarks | 408 |  |  | (155) |  |  | 253 |  |  | 409 |  |  | (137) |  |  | 271 |
Patents and other | 542 |  |  | (346) |  |  | 196 |  |  | 523 |  |  | (339) |  |  | 184 |
Amortized intangible assets | $ | 20,987 |  |  | $ | (8,723) |  |  | $ | 12,264 |  |  | $ | 20,106 |  |  | $ | (7,381) |  |  | $ | 12,726 |
Unamortized intangible assets |  |  |  |  |  |  |  |  |  |  |
Acquired in-process research and development | $ | 44 |  |  |  |  |  |  | $ | 44 |  |  |  |  |
Trademarks | 2 |  |  |  |  |  |  | 2 |  |  |  |  |
Unamortized intangible assets | $ | 46 |  |  |  |  |  |  | $ | 46 |  |  |  |  |
Intangible amortization expense was $1.430 billion, $1.402 billion and $1.384 billion in 2022, 2021 and 2020, respectively. The estimated aggregate amortization expense for the fiscal years ending September 30, 2023 to 2027 are as follows: 2023 — $1.385 billion; 2024 — $1.382 billion; 2025 — $1.381 billion; 2026 — $1.350 billion; 2027 — $1.292 billion. The following is a reconciliation of goodwill by business segment:
(Millions of dollars) | Medical |  | Life Sciences |  | Interventional |  | Total
Goodwill as of September 30, 2020 | $ | 10,028 |  |  | $ | 837 |  |  | $ | 12,739 |  |  | $ | 23,604 |
Acquisitions (a) | 193 |  |  | — |  |  | 72 |  |  | 264 |
Purchase price allocation adjustments | 4 |  |  | — |  |  | 1 |  |  | 6 |
Currency translation | 15 |  |  | (1) |  |  | (2) |  |  | 12 |
Goodwill as of September 30, 2021 | $ | 10,240 |  |  | $ | 836 |  |  | $ | 12,810 |  |  | $ | 23,886 |
Acquisitions (b) | 814 |  |  | 71 |  |  | 188 |  |  | 1,073 |
Purchase price allocation adjustments | 1 |  |  | — |  |  | (2) |  |  | (1) |
Currency translation | (145) |  |  | (20) |  |  | (171) |  |  | (337) |
Goodwill as of September 30, 2022 | $ | 10,909 |  |  | $ | 888 |  |  | $ | 12,824 |  |  | $ | 24,621 |
(a)Represents goodwill recognized relative to certain acquisitions which were not material individually or in the aggregate. (b)Primarily represents goodwill recognized in the Medical segment upon the Company's acquisition of Parata, which is further discussed in Note 11. Also includes goodwill recognized relative to certain acquisitions which were not material individually or in the aggregate.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI https://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration